The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of pCR with pretreatment MRI radiomics in triple negative breast cancer treated with neoadjuvant chemo-immunotherapy.
 
Toulsie Ramtohul
No Relationships to Disclose
 
Victoire Lepagnay
No Relationships to Disclose
 
Claire Bonneau
No Relationships to Disclose
 
Maxime Jin
No Relationships to Disclose
 
Emmanuelle Menet
No Relationships to Disclose
 
Juliette Sauge
No Relationships to Disclose
 
Enora Laas
No Relationships to Disclose
 
Emanuela Romano
Honoraria - Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Replimune (Inst); Roche/Genentech (Inst)
Research Funding - Amgen; Bristol-Myers Squibb; Replimune (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Roche
 
Diana Bello
Travel, Accommodations, Expenses - daiichi sankyo; Lilly
 
Fatima Mechta-Grigoriou
Research Funding - Roche (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent: Methods for the treatment of fibrotic related diseases Application number: EP23306606.7 Djerroudi L, Vincent-Salomon A. and Mechta-Grigoriou F (Inst); Patent: New populations of fibroblasts and macrophages as prognosis markers for detection of fibroblasts associated diseases Application number: EP23306326.2 Cohen C and Mechta-Grigoriou F (Inst)
Travel, Accommodations, Expenses - 10X Genomics
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi-Sankyo; Exact Sciences; GE Healthcare; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche; SAGA Diagnostics
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Menarini Group; Novartis; Pfizer
Research Funding - GE Healthcare (Inst); Menarini Silicon Biosystems (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Personalis (Inst); Pfizer (Inst); Prolynx (Inst); SAGA Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - ESR1 & MSI detection techniques (patents) (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer; Roche
 
Adriana Langer
No Relationships to Disclose
 
Caroline Malhaire
No Relationships to Disclose
 
Luc Cabel
No Relationships to Disclose
 
Anne Tardivon
No Relationships to Disclose